Bioresorbable Vascular Scaffold Market Size, Share & Trends Analysis Report By Application (Peripheral Artery, Coronary Artery), By End-use ((Hospitals, Ambulatory Care Centers, Specialty Clinics), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Bioresorbable Vascular Scaffold Market Growth & Trends
The global bioresorbable vascular scaffold market size is expected to reach USD 715.09 million by 2030, expanding at a CAGR of 8.7% from 2024 to 2030, based on a new Grand View Research, Inc. report. The market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and the need for effective, minimally invasive treatments. According to the 2024 Heart Disease and Stroke Statistics Update Fact Sheet, cardiovascular disease (CVD) remains a significant public health concern in the U.S., with 931,578 deaths attributed to it as the underlying cause in 2021. The impact of heart disease and stroke is staggering, as they claimed more lives in 2021 than all forms of cancer and chronic lower respiratory disease combined.
The prevalence of CVD is alarmingly high, with 127.9 million US adults (48.6%) having some form of the disease between 2017 and 2020. The economic burden of CVD is also substantial, with direct and indirect costs totaling USD 422.3 billion between 2019 and 2020, including USD 254.3 billion in direct costs and USD 168.0 billion in lost productivity and mortality. These statistics underscore the urgent need for continued research, prevention, and treatment efforts to address the growing burden of cardiovascular disease in the U.S.
In addition to the increasing prevalence of CVD, technological advancements in the bioresorbable vascular scaffold (BVS) and a robust product pipeline are other factors expected to drive the growth of the market during the forecast period. For instance, in April 2024, the US Food and Drug Administration approved an everolimus-eluting bioresorbable scaffold (Esprit BTK) for patients with below-the-knee (BTK) infrapopliteal disease, according to an announcement from manufacturer Abbott. This approval highlights the ongoing development and innovation in the BVS market, providing new treatment options for patients with cardiovascular conditions.
Moreover, the evolution of next-generation bioresorbable vascular scaffolds (BRSs) with enhanced mechanical properties is a significant catalyst driving the global market's expansion. Previous versions of BRSs encountered challenges such as thicker struts and higher crossing profiles, limiting their widespread application. However, the latest BRSs utilize absorbable materials with superior mechanical attributes, enabling the production of thinner struts and reduced crossing profiles, improving deliverability, conformability, and flexibility for complex lesions and smaller vessels.
These advancements have resulted in improved clinical outcomes, including enhanced vessel healing, reduced restenosis rates, and decreased risks of adverse events like stent thrombosis, fostering increased adoption of BRSs worldwide. The growing preference for minimally invasive procedures, an aging population, and the escalating prevalence of cardiovascular diseases globally indicate a promising trajectory for the market on a global scale.
Bioresorbable Vascular Scaffold Market Report Highlights
Bioresorbable Vascular Scaffold Market Growth & Trends
The global bioresorbable vascular scaffold market size is expected to reach USD 715.09 million by 2030, expanding at a CAGR of 8.7% from 2024 to 2030, based on a new Grand View Research, Inc. report. The market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases and the need for effective, minimally invasive treatments. According to the 2024 Heart Disease and Stroke Statistics Update Fact Sheet, cardiovascular disease (CVD) remains a significant public health concern in the U.S., with 931,578 deaths attributed to it as the underlying cause in 2021. The impact of heart disease and stroke is staggering, as they claimed more lives in 2021 than all forms of cancer and chronic lower respiratory disease combined.
The prevalence of CVD is alarmingly high, with 127.9 million US adults (48.6%) having some form of the disease between 2017 and 2020. The economic burden of CVD is also substantial, with direct and indirect costs totaling USD 422.3 billion between 2019 and 2020, including USD 254.3 billion in direct costs and USD 168.0 billion in lost productivity and mortality. These statistics underscore the urgent need for continued research, prevention, and treatment efforts to address the growing burden of cardiovascular disease in the U.S.
In addition to the increasing prevalence of CVD, technological advancements in the bioresorbable vascular scaffold (BVS) and a robust product pipeline are other factors expected to drive the growth of the market during the forecast period. For instance, in April 2024, the US Food and Drug Administration approved an everolimus-eluting bioresorbable scaffold (Esprit BTK) for patients with below-the-knee (BTK) infrapopliteal disease, according to an announcement from manufacturer Abbott. This approval highlights the ongoing development and innovation in the BVS market, providing new treatment options for patients with cardiovascular conditions.
Moreover, the evolution of next-generation bioresorbable vascular scaffolds (BRSs) with enhanced mechanical properties is a significant catalyst driving the global market's expansion. Previous versions of BRSs encountered challenges such as thicker struts and higher crossing profiles, limiting their widespread application. However, the latest BRSs utilize absorbable materials with superior mechanical attributes, enabling the production of thinner struts and reduced crossing profiles, improving deliverability, conformability, and flexibility for complex lesions and smaller vessels.
These advancements have resulted in improved clinical outcomes, including enhanced vessel healing, reduced restenosis rates, and decreased risks of adverse events like stent thrombosis, fostering increased adoption of BRSs worldwide. The growing preference for minimally invasive procedures, an aging population, and the escalating prevalence of cardiovascular diseases globally indicate a promising trajectory for the market on a global scale.
Bioresorbable Vascular Scaffold Market Report Highlights
- The coronary artery segment accounted for a revenue share of 84.59% in 2023. This is due to the high prevalence of coronary artery diseases and the increasing demand for minimally invasive treatments. Additionally, the advancements in bioresorbable scaffold technology have led to improved device performance and patient outcomes, further driving the growth of this segment.
- The hospitals segment held the largest revenue share of over 74.21% in 2023. This is due to the high volume of cardiovascular procedures performed in hospitals and the availability of advanced medical facilities. Additionally, hospitals often serve as referral centers for complex cases, further driving the demand for bioresorbable vascular scaffolds.For instance, in 2023, hospitals in the U.S. performed over 900,000 coronary interventions, according to the American College of Cardiology. This high procedure volume, coupled with the benefits of bioresorbable vascular scaffolds, such as reduced long-term complications and improved patient outcomes, contributes to the hospital segment's leading market share.
- In 2023, North America led the market share, due to the presence of a large patient pool suffering from cardiovascular diseases, a well-established healthcare infrastructure, and a high adoption rate of advanced medical technologies. Additionally, the region is home to several key players in the market, such as Abbott, Boston Scientific Corporation, and Medtronic, which are continuously investing in R&D activities to develop innovative products and expand their market presence.
- Market players are implementing various strategic initiatives to enhance product reach and availability across different geographic regions.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application Type
1.2.2. End-use channel
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. BIORESORBABLE VASCULAR SCAFFOLD MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Bioresorbable Vascular Scaffold Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. BIORESORBABLE VASCULAR SCAFFOLD MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Bioresorbable Vascular Scaffold Market: Application Dashboard
4.2. Bioresorbable Vascular Scaffold Market: Application Movement Analysis
4.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Peripheral Artery
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Coronary Artery
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Bioresorbable Vascular Scaffold Market: End-use Dashboard
5.2. Bioresorbable Vascular Scaffold Market: End-use Movement Analysis
5.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Ambulatory Care Centers (ACS)
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Specialty Clinics
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. BIORESORBABLE VASCULAR SCAFFOLD MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, PRODUCT, AND END-USE
6.1. Bioresorbable Vascular Scaffold Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Application benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Kyoto Medical
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Application benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Biotronik
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Application benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Elixir Medical
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Application benchmarking
7.3.7.4. Strategic initiatives
7.3.8. C. R. Bard, Inc.,
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Application benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Teleflex Incorporated
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Application benchmarking
7.3.9.4. Strategic initiatives
7.3.10. B. Braun Melsungen AG
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Application benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Medtronic Plc
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Application benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Argon Medical Devices, Inc
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Application benchmarking
7.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application Type
1.2.2. End-use channel
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. BIORESORBABLE VASCULAR SCAFFOLD MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Bioresorbable Vascular Scaffold Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. BIORESORBABLE VASCULAR SCAFFOLD MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Bioresorbable Vascular Scaffold Market: Application Dashboard
4.2. Bioresorbable Vascular Scaffold Market: Application Movement Analysis
4.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Peripheral Artery
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Coronary Artery
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. GLOBAL BIORESORBABLE VASCULAR SCAFFOLD MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Bioresorbable Vascular Scaffold Market: End-use Dashboard
5.2. Bioresorbable Vascular Scaffold Market: End-use Movement Analysis
5.3. Bioresorbable Vascular Scaffold Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Ambulatory Care Centers (ACS)
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Specialty Clinics
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. BIORESORBABLE VASCULAR SCAFFOLD MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, PRODUCT, AND END-USE
6.1. Bioresorbable Vascular Scaffold Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Application benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Kyoto Medical
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Application benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Biotronik
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Application benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Elixir Medical
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Application benchmarking
7.3.7.4. Strategic initiatives
7.3.8. C. R. Bard, Inc.,
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Application benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Teleflex Incorporated
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Application benchmarking
7.3.9.4. Strategic initiatives
7.3.10. B. Braun Melsungen AG
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Application benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Medtronic Plc
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Application benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Argon Medical Devices, Inc
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Application benchmarking
7.3.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 4 Global bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America bioresorbable vascular scaffold market, by region, 2018 - 2030 (USD Million)
Table 6 North America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 7 North America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S. bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 11 Canada bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 13 Mexico bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 15 Europe bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 16 Europe bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 17 UK bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 18 UK bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 20 Germany bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 21 France bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 22 France bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 23 Italy bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 24 Italy bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 25 Spain bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 26 Spain bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 27 Norway bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 28 Norway bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 29 Sweden bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 30 Sweden bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 32 Denmark bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 35 Asia Pacific bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 36 Japan bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 37 Japan bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 38 China bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 39 China bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 40 India bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 41 India bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 42 Australia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 43 Australia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 44 South Korea bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 45 South Korea bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 46 Thailand bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 47 Thailand bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 48 Latin America bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 50 Latin America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 51 Brazil bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 52 Brazil bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 53 Argentina bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 54 Argentina bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 59 South Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 62 UAE bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 63 UAE bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 64 Kuwait bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 65 Kuwait bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 4 Global bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 5 North America bioresorbable vascular scaffold market, by region, 2018 - 2030 (USD Million)
Table 6 North America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 7 North America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 8 U.S. bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 11 Canada bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 12 Mexico bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 13 Mexico bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 14 Europe bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 15 Europe bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 16 Europe bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 17 UK bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 18 UK bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 19 Germany bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 20 Germany bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 21 France bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 22 France bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 23 Italy bioresorbable vascular scaffold market, by product type, 2018 - 2030 (USD Million)
Table 24 Italy bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 25 Spain bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 26 Spain bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 27 Norway bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 28 Norway bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 29 Sweden bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 30 Sweden bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 31 Denmark bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 32 Denmark bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 33 Asia Pacific bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 35 Asia Pacific bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 36 Japan bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 37 Japan bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 38 China bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 39 China bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 40 India bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 41 India bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 42 Australia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 43 Australia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 44 South Korea bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 45 South Korea bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 46 Thailand bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 47 Thailand bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 48 Latin America bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 50 Latin America bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 51 Brazil bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 52 Brazil bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 53 Argentina bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 54 Argentina bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa bioresorbable vascular scaffold market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Africa bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 59 South Africa bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 62 UAE bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 63 UAE bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
Table 64 Kuwait bioresorbable vascular scaffold market, by application, 2018 - 2030 (USD Million)
Table 65 Kuwait bioresorbable vascular scaffold market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modelling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Bioresorbable vascular scaffold market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Bioresorbable vascular scaffold market application market share analysis, 2023 & 2030
Fig. 14 Bioresorbable vascular scaffold market application market: Application Segment dashboard
Fig. 15 Peripheral artery market, 2018 - 2030 (USD Million)
Fig. 16 Coronary artery market, 2018 - 2030 (USD Million)
Fig. 17 Bioresorbable vascular scaffold market by end-use market share analysis, 2023 & 2030
Fig. 18 Bioresorbable vascular scaffold market by end-use market: Segment dashboard
Fig. 19 Hospitals, 2018 - 2030 (USD Million)
Fig. 20 Ambulatory Care Centers, 2018 - 2030 (USD Million)
Fig. 21 Speciality Clinics, 2018 - 2030 (USD Million)
Fig. 22 Bioresorbable vascular scaffold market by regional market share analysis, 2023 & 2030
Fig. 23 Bioresorbable vascular scaffold market: Regional dashboard
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 North America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 26 U.S. bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 27 Canada bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 28 Mexico bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 29 Europe bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 30 UK bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 31 France bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 32 Germany bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 33 Italy bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 34 Spain bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 35 Denmark bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 36 Norway bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 37 Sweden bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 39 Japan bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 40 China bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 41 India bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 42 Australia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 43 South Korea bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 44 Thailand bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 45 Latin America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 46 Brazil bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 47 Argentina bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 48 MEA bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 50 South Africa bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 51 UAE bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 52 Kuwait bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 53 Company market position analysis
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modelling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Market outlook
Fig. 8 Bioresorbable vascular scaffold market segmentation
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market trends & outlook
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Bioresorbable vascular scaffold market application market share analysis, 2023 & 2030
Fig. 14 Bioresorbable vascular scaffold market application market: Application Segment dashboard
Fig. 15 Peripheral artery market, 2018 - 2030 (USD Million)
Fig. 16 Coronary artery market, 2018 - 2030 (USD Million)
Fig. 17 Bioresorbable vascular scaffold market by end-use market share analysis, 2023 & 2030
Fig. 18 Bioresorbable vascular scaffold market by end-use market: Segment dashboard
Fig. 19 Hospitals, 2018 - 2030 (USD Million)
Fig. 20 Ambulatory Care Centers, 2018 - 2030 (USD Million)
Fig. 21 Speciality Clinics, 2018 - 2030 (USD Million)
Fig. 22 Bioresorbable vascular scaffold market by regional market share analysis, 2023 & 2030
Fig. 23 Bioresorbable vascular scaffold market: Regional dashboard
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 North America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 26 U.S. bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 27 Canada bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 28 Mexico bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 29 Europe bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 30 UK bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 31 France bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 32 Germany bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 33 Italy bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 34 Spain bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 35 Denmark bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 36 Norway bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 37 Sweden bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 39 Japan bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 40 China bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 41 India bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 42 Australia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 43 South Korea bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 44 Thailand bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 45 Latin America bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 46 Brazil bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 47 Argentina bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 48 MEA bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 49 Saudi Arabia bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 50 South Africa bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 51 UAE bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 52 Kuwait bioresorbable vascular scaffold market, 2018 - 2030 (USD Million)
Fig. 53 Company market position analysis
